Bright Green Corporation (BGXX)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -8.89 Million USD | 60.49% |
| 2022 | -27.31 Million USD | -996.72% |
| 2021 | -2.49 Million USD | 12.46% |
| 2020 | -2.84 Million USD | -226.85% |
| 2019 | -870.47 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.52 Million USD | 18.85% |
| 2024 Q1 | -1.87 Million USD | -26.82% |
| 2023 Q3 | -1.95 Million USD | 34.53% |
| 2023 FY | -10.79 Million USD | 60.49% |
| 2023 Q4 | -1.48 Million USD | 24.27% |
| 2023 Q1 | -2.61 Million USD | -60.34% |
| 2023 Q2 | -2.98 Million USD | -14.31% |
| 2022 Q2 | -12.88 Million USD | -1673.69% |
| 2022 Q1 | -726.34 Thousand USD | 21.16% |
| 2022 FY | -27.31 Million USD | -996.72% |
| 2022 Q4 | -1.62 Million USD | 71.79% |
| 2022 Q3 | -5.77 Million USD | 55.16% |
| 2021 Q4 | -921.29 Thousand USD | -46.65% |
| 2021 FY | -2.49 Million USD | 12.46% |
| 2021 Q3 | -628.21 Thousand USD | -45.6% |
| 2021 Q2 | -431.47 Thousand USD | 15.32% |
| 2021 Q1 | -509.54 Thousand USD | 13.65% |
| 2020 FY | -2.84 Million USD | -226.85% |
| 2020 Q4 | -590.1 Thousand USD | 52.12% |
| 2020 Q3 | -1.23 Million USD | -50.19% |
| 2020 Q2 | -820.63 Thousand USD | -45.72% |
| 2020 Q1 | -563.15 Thousand USD | 0.0% |
| 2019 FY | -870.47 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 105.325% |
| Embecta Corp. | 221.5 Million USD | 104.014% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 118.93% |
| Dynavax Technologies Corporation | -37.02 Million USD | 75.987% |
| Esperion Therapeutics, Inc. | -155.56 Million USD | 94.284% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 110.141% |
| PainReform Ltd. | -9.58 Million USD | 7.227% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | 41.124% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -85.806% |
| SCYNEXIS, Inc. | 72.66 Million USD | 112.235% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -253.503% |
| Cosmos Health Inc. | -21.83 Million USD | 59.272% |
| Journey Medical Corporation | -2.07 Million USD | -328.914% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -85.806% |
| Safety Shot Inc | -12.18 Million USD | 27.025% |
| Alpha Teknova, Inc. | -35.56 Million USD | 74.998% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 94.421% |
| Procaps Group, S.A. | 38.97 Million USD | 122.814% |
| Theratechnologies Inc. | -10.62 Million USD | 16.332% |
| Harrow Health, Inc. | 580 Thousand USD | 1632.997% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | -89.138% |
| Biofrontera Inc. | -22.67 Million USD | 60.791% |
| DURECT Corporation | -36.88 Million USD | 75.894% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -68.749% |
| Cronos Group Inc. | -81.37 Million USD | 89.074% |
| OptiNose, Inc. | -22.74 Million USD | 60.914% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 104.254% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 77.291% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 170.388% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 170.989% |
| Guardion Health Sciences, Inc. | -4.33 Million USD | -105.045% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | -43.16% |
| Radius Health, Inc. | -3.92 Million USD | -126.532% |
| Universe Pharmaceuticals INC | -3.52 Million USD | -152.111% |
| ProPhase Labs, Inc. | -21.61 Million USD | 58.861% |
| Phibro Animal Health Corporation | 53.31 Million USD | 116.677% |
| Procaps Group S.A. | 52.32 Million USD | 116.993% |
| Alvotech | -354.86 Million USD | 97.494% |
| TherapeuticsMD, Inc. | -8.52 Million USD | -4.322% |
| Viatris Inc. | 766.2 Million USD | 101.16% |
| Rockwell Medical, Inc. | -6.67 Million USD | -33.304% |
| Aytu BioPharma, Inc. | -5.25 Million USD | -69.231% |
| SIGA Technologies, Inc. | 83.62 Million USD | 110.633% |
| Tilray Brands, Inc. | -174.74 Million USD | 94.912% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 195.289% |
| Shineco, Inc. | -17.06 Million USD | 47.9% |
| PetIQ, Inc. | 60.01 Million USD | 114.815% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | -87.712% |
| Incannex Healthcare Limited | -30.04 Million USD | 70.403% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 103.544% |
| Alimera Sciences, Inc. | -1.47 Million USD | -504.445% |
| Silver Spike Investment Corp. | 7.34 Million USD | 221.134% |
| Assertio Holdings, Inc. | -243.53 Million USD | 96.349% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | -50.896% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | 34.706% |
| Clever Leaves Holdings Inc. | -15.59 Million USD | 42.982% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 55.654% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 93.55% |
| Hempacco Co., Inc. | -8.81 Million USD | -0.898% |
| Talphera, Inc. | -16.88 Million USD | 47.354% |
| Alvotech | -354.86 Million USD | 97.494% |
| Eagle Pharmaceuticals, Inc. | 53.45 Million USD | 116.634% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 102.438% |
| Currenc Group, Inc. | -6.64 Million USD | -33.79% |
| Kamada Ltd. | 10.06 Million USD | 188.348% |
| Indivior PLC | -4 Million USD | -122.285% |
| Evoke Pharma, Inc. | -7.43 Million USD | -19.654% |
| Flora Growth Corp. | -50.35 Million USD | 82.342% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 55.654% |
| Evolus, Inc. | -49.23 Million USD | 81.94% |
| HUTCHMED (China) Limited | 18.37 Million USD | 148.388% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 104.514% |
| Akanda Corp. | -10.05 Million USD | 11.541% |